What to know about stopping the J&J COVID vaccine


April 13, 2021 – after receiving rare reports blood clot In people who receive the Johnson & Johnson COVID-19 virus Serum, The FDA and the CDC recommend that you stop using SerumPending further investigation.

Here, what you need to know:

Why was the stoppage suggested?

After reviewing the data, the agencies found six reports of people who experienced rare cases Blood clots In combination with the lower platelet count, they are the smallest Blood cells It is involved in coagulation. The six reports were found out of more than 6.8 million doses given. The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have started pausing “out of great caution”.

What else is known?

According to a joint statement from the CDC and the FDA, all six cases were in women between the ages of 18 and 48. Symptoms occurred 6-13 days after vaccination. The type of clot is known medically as cerebral venous Lumen Coagulopathy (CVST) was seen in association with low levels of platelets. Go here to learn more About these types of blood clots.

Among the six cases, a woman died. Another was in critical condition.

The Center for Disease Control and the Food and Drug Administration say treatment for this type of stroke is different from treatment for the other types. Usually, an anticoagulant medication, Heparin, Uses. But for this type of thrombosis, an alternative treatment may be required.

Why is this happening?

“We don’t have a definitive answer at this time, but it appears to involve an immune response associated with the J&J vaccine that negatively affects platelet function, which in turn prevents the normal clotting process,” says Robert Glatter. , M.D., emergency physician at Lenox Hill Hospital in New York City.

The explanation “may ultimately be related to the adenovirus vector,” he says [used in the vaccine] Itself.”

Why does it seem to affect women more than men?

This is not yet known, says William Schaffner, professor of preventive medicine and infectious disease specialist at Vanderbilt University Medical Center in Nashville. “This was true of AstraZeneca [vaccine] In addition to their blood clotting problems, ”he says. If it is an immune problem, women tend to have a lot more of these problems than men, in general, he says.

What should people who get the Johnson & Johnson vaccine know and do?

Keep in mind that reports of blood clots have been rare, Schaffner suggests. The odds are about 1 in a million, based on the six reports out of the 6.8 million doses administered. “This is actually evidence of the sensitivity of our vaccine safety system,” he says. Those few reports out of millions of doses will be revealed.

The Food and Drug Administration and the CDC say people who get the vaccine should be alert to symptoms. If you get a Johnson & Johnson vaccine and develop a severe headache, Stomach acheLeg pain or shortness of breath within 3 weeks of vaccination, contact your healthcare provider.

How long will the suspension last?

This also is not yet known. The Centers for Disease Control and Prevention (CDC) Immunization Practices Advisory Committee (ACIP) will meet on Wednesday to further review cases and “assess their potential significance.” The Food and Drug Administration is also reviewing the data further.

WebMD Health News


CDC: “A joint statement by the Centers for Disease Control and Prevention and the Food and Drug Administration regarding the Johnson & Johnson COVID-19 vaccine.”

Johnson & Johnson: “Johnson & Johnson Statement on COVID-19 Vaccine.”

William Schaffner, MD, Professor of Preventive Medicine and Infectious Diseases Specialist, Vanderbilt University Medical Center, Nashville.

Robert Glater, Emergency Physician, Lenox Hill Hospital, New York City.

© 2021 WebMD, LLC. All rights reserved.